Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.
Sell
35
KROS
Keros Therapeutics
Last Price:
54.72
Seasonality Move:
30.98%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.76 | Buy |
20-day SMA: | 47.67 | Buy |
50-day SMA: | 47.49 | Buy |
200-day SMA: | 51.25 | Buy |
8-day EMA: | 51.52 | Buy |
20-day EMA: | 49.13 | Buy |
50-day EMA: | 48.47 | Buy |
200-day EMA: | 49.07 | Buy |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.62 | Buy |
Relative Strength Index (14 RSI): | 69.26 | Buy |
Chaikin Money Flow: | 103447 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.92 - 50.62) | Buy |
Bollinger Bands (100): | (44.89 - 54.25) | Buy |
Keros Therapeutics Technical Analysis
Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 54.69 while KROS 8-day simple moving average is 50.76, which is a Buy signal.
- The stock price of KROS is 54.69 while Keros Therapeutics 20-day SMA is 47.67, which makes it a Buy.
- Keros Therapeutics 50-day simple moving average is 47.49 while KROS share price is 54.69, making it a Buy technically.
- KROS stock price is 54.69 and Keros Therapeutics 200-day simple moving average is 51.25, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $54.69. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
2.05B
Price in USD:
54.69
Share Volume:
271.08K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Sell
35
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 54.69 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 54.69 while KROS 8-day exponential moving average is 51.52, which is a Buy signal.
- The stock price of KROS is 54.69 while Keros Therapeutics 20-day EMA is 49.13, which makes it a Buy.
- Keros Therapeutics 50-day exponential moving average is 48.47 while KROS share price is 54.69, making it a Buy technically.
- KROS stock price is 54.69 and Keros Therapeutics 200-day simple moving average is 49.07, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.41 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is 1.62, suggesting Keros Therapeutics is a Buy
- Keros Therapeutics Relative Strength Index (RSI) is 69.26, which suggest Keros Therapeutics is overbought
- The Bollinger Bands (25) for Keros Therapeutics is (43.92 - 50.62), which suggest Keros Therapeutics is a Buy
- The Bollinger Bands (100) for Keros Therapeutics is (44.89 - 54.25), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.